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During the resolution of inflammation, macrophages engulf apoptotic polymorphonuclear 
cells (PMN) and can accumulate large numbers of their corpses. Here, we report that 
resolution phase macrophages acquire the neutrophil-derived glycoprotein lactoferrin 
(Lf) and fragments thereof in vivo and ex vivo. During the onset and resolving phases of 
inflammation in murine peritonitis and bovine mastitis, Lf fragments of 15 and 17 kDa 
occurred in various body fluids, and the murine fragmentation, accumulation, and release 
were mediated initially by neutrophils and later by efferocytic macrophages. The 17-kDa 
fragment contained two bioactive tripeptides, FKD and FKE that promoted resolution 
phase macrophage conversion to a pro-resolving phenotype. This resulted in a reduction 
in peritoneal macrophage numbers and an increase in the CD11blow subset of these 
cells. Moreover, FKE, but not FKD, peptides enhanced efferocytosis of apoptotic PMN, 
reduced TNFα and interleukin (IL)-6, and increased IL-10 secretion by lipopolysaccha-
ride-stimulated macrophages ex vivo. In addition, FKE promoted neutrophil-mediated 
resolution at high concentrations (100  µM) by enhancing the formation of cytokine- 
scavenging aggregated NETs (tophi) at a low cellular density. Thus, PMN Lf is processed, 
acquired, and “recycled” by neutrophils and macrophages during inflammation resolution 
to generate fragments and peptides with paramount pro-resolving activities.
Keywords: resolution of inflammation, lactoferrin, macrophages, efferocytosis, neTosis
inTrODUcTiOn
The clearance of apoptotic cells is essential for proper development, homeostasis, and the termina-
tion of immune responses (1, 2). The engulfment of apoptotic polymorphonuclear cells (PMN) by 
macrophages during the resolution of inflammation, in particular, is considered to be a hallmark 
and a major fate-determining event for these cells (3–6). The phagocytosis of apoptotic cells and 
Abbreviations: aggNETs, aggregated neutrophil extracellular traps; ATP, adenosine triphosphate; BMEC, bovine mammary 
gland epithelial cells; CID, collision-induced dissociation; ELISA, enzyme-linked immunosorbent assay; FCS, fetal calf serum; 
IgG, immunoglobulin G; IL, interleukin; ISF, interstitial fluid; LBs, latex beads; Lf, lactoferrin; LFPs, lactoferrin peptides; 
LPS, lipopolysaccharide; LN, lymph nodes; MCP-1, monocyte chemotactic protein-1; NF-κB, nuclear factor kappa B; PMA, 
phorbol myristate acetate; PMN, polymorphonuclear cells; PPI, post-peritonitis initiation; PVDF, polyvinylidene difluoride; 
RIPA, radioimmunoprecipitation assay; ROS, reactive oxygen species; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis; TGFβ, tumor growth factor β; TNFα, tumor necrosis factor α.
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phagolysosome maturation reportedly result in the degradation 
of the apoptotic cell content (7). However, neutrophil-derived 
defensins were preserved and transferred from engulfed apop-
totic PMN to the phagolysosomes in the engulfing macrophage 
(8). Here, they limit the intracellular growth of Mycobacterium 
tuberculosis. It has been shown that CD11blow macrophages 
emerge during the resolution of inflammation (9). These satiated 
phagocytes engulf high numbers of apoptotic PMN and consecu-
tively migrate to spleen and inguinal lymph nodes (LN) (9).
Lactoferrin (Lf), an iron-binding glycoprotein from the 
transferrin family with a molecular weight of 78 kDa, is found 
in various body fluids like milk, colostrum, saliva, tears, mucus 
secretions, as well as in neutrophil secondary granules (10). 
Neutrophil degranulation is the main source of Lf in blood (11). 
Lf is endowed with a plethora of biological functions, including 
antimicrobial, antiviral, antiparasite, anti-inflammatory, and 
anticancer activities (12). Lf-binding proteins have been detected 
on the surfaces of various cells, including neutrophils, monocytes, 
and peritoneal macrophages (13, 14), as well as on the surfaces 
of various microorganisms (15). Lf is an important pro-resolving 
mediator when it is released from apoptotic neutrophils, i.e., it 
blocks the directed migration of neutrophils and eosinophils 
(16, 17). The region(s) of Lf responsible for its bactericidal prop-
erties is still elusive, although the primary sequences of human 
Lf and bovine Lf are known, and the molecular structure of this 
protein has been studied by X-ray crystallography. Numerous 
studies found that pepsin-digested Lf has a stronger antimicrobial 
activity than the native protein. A peptide fragment of Lf that 
exerts antimicrobial activity is referred to as lactoferricin (18). 
Komine et  al. reported that cleavage by the neutrophil-borne 
serine proteases elastase and/or proteinase 3 of human or bovine 
Lf generated several bioactive oligopeptides (19, 20). One of these 
oligopeptides (PGQRDLLFKDSAL) promoted the secretion of 
pro-inflammatory cytokines and chemokines [interleukin (IL)-6, 
IL-8, tumor necrosis factor α (TNFα), and monocyte chemotactic 
protein-1 (MCP-1)] by bovine mammary epithelial cells, whereas 
its human homolog induced the production of IL-6, MCP-1, and 
IL-8. In addition, it activated nuclear factor kappa B (NF-κB) in 
human oral epithelial HSC-2 cells (20). An additional sequence 
(FKDCHLA) that also contains an FKD motif showed similar 
pro-inflammatory properties (20), whereas its bovine counter-
part (FKECHLA) was inactive (19). Hence, Lf can be cleaved 
into bioactive peptides that display activities different from the 
established antibacterial properties.
Recent reports have indicated that the accumulation of neu-
trophils in high density in vivo or in vitro and their activation 
with monosodium urate (MSU) crystals leads to the generation 
of aggregated neutrophil extracellular traps (aggNETs) in a reac-
tive oxygen species-dependent manner (21). These tophus-like 
structures promote the degradation of inflammatory cytokines 
through cleavage by associated serine proteases (21). However, 
especially in glandular tissues, aggNETs may carry the risk to 
occlude ducts and secondarily precipitate inflammatory reac-
tions (22). Lf and adenosine triphosphate enhanced aggNETs 
formation in low-density neutrophil cultures (21). This suggests 
that Lf and serine proteases cooperate in the resolution of 
inflammation.
Here, we report that murine resolution phase macrophages 
contain truncated forms of Lf that are generated by aged/senes-
cent PMN and are acquired following their engulfment. In turn, 
distinct shorter fragments of Lf are found in body fluids during the 
inflammatory and resolving phases of both murine peritonitis and 
bovine mastitis. A resolution-associated fragment of Lf contained 
two tripeptides that modulated in vivo pro-resolving properties of 
macrophages as well as the formation of aggNETs. These results 
suggest that macrophages acquire Lf from senescent PMN, pro-
cess it to shorter bioactive peptides, and fragments thereof release 
them in a temporal manner. These peptides in turn promote 
pro-resolving actions of neutrophils and macrophages, as needed.
MaTerials anD MeThODs
reagents
The following reagents were purchased as detailed: acrylamide/
bis-acrylamide, fibronectin, lipopolysaccharide (LPS) (from 
Escherichia coli, clone 055:B5), staurosporine, TEMED, Tween-
20, the neutrophil elastase inhibitor silevestat, and zymosan A 
from Sigma-Aldrich; clodronate from Liposoma BV; anti-goat 
horseradish peroxidase-conjugated immunoglobulin G (IgG) 
and anti-rabbit horseradish peroxidase-conjugated IgG from 
Jackson Immuno Research Laboratories; WesternBright™ ECL 
from Advansta, fetal calf serum (FCS), L-glutamine, penicil-
lin–streptomycin, RPMI 1640 and trypan blue from Biological 
Industries, Kibbutz Beit Haemek; goat anti-mouse CD11b (M-19) 
polyclonal IgG and rabbit anti-human Lf (H-65) polyclonal IgG 
from SantaCruz Biotechnology; FITC-conjugated anti-mouse 
Gr-1, PE-conjugated anti-mouse F4/80, PerCP-conjugated anti-
mouse CD11b, APC-conjugated anti-mouse CXCR4 (clone BL6-
146508) and enzyme-linked immunosorbent assay (ELISA) kits 
for TNFα, IL-6, IL-12, and IL-10 from Biolegend; cycloheximide 
(CHX) from Cayman Chemical; PE selection kit was purchased 
from Stem Cell Technologies; and Protease Inhibitors Cocktail 
was purchased from Roche. FKD and FKE peptides were organi-
cally synthesized by GL Biochem (Shanghai) Ltd.
Murine Peritonitis
Male C57BL/6 mice (6–8 weeks from Harlan Biotech, protocol 
approved by the Committee of Ethics, The Technion, authori-
zation no. IL-065-04-2010) were injected intraperitoneally 
(i.p.) with sterile zymosan A (1  mg/ml in PBS). At 24 or 66 h 
post-peritonitis initiation (PPI), mice were euthanized using 
isoflurane, and peritoneal exudates were collected by lavaging 
with 5 ml of sterile PBS. In some experiments, mice challenged 
with zymosan A for 42 h or unchallenged were injected i.p. with 
pre-made liposomal clodronate (1 or 0.1 mg/mouse, respectively) 
or empty liposomes. Then, unchallenged mice were injected with 
zymosan A. After additional 24 h, peritoneal fluids and spleens 
were collected from all mice and analyzed for leukocyte subsets 
by flow cytometry and by Western blotting for Lf as indicated 
below. Clodronate treatment resulted in an 84% reduction in 
peritoneal macrophages and no significant changes in the per-
centage of splenic macrophages. In other experiments, vehicle, 
FKD, or FKE peptides (50  µM) were injected i.p. at 48 h PPI, 
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and peritoneal exudates were recovered at 66 h. Macrophages 
from the exudates were evaluated for CD11b expression, their 
apoptotic PMN content, and reprogrammed cytokine secretion 
as detailed below.
apoptosis induction
Jurkat T  cells (1 ×  106 cell/ml) were cultured in culture media 
(RPMI 1640 supplemented with 10% FCS, 2 mM L-glutamine, 
100  µg/ml streptomycin, and 100  U/ml penicillin) under a 
humidified 5% CO2 atmosphere at 37°C. Apoptosis was induced 
by staurosporine (1 µM) for 4 h. PMN cells were isolated from 
peritoneal exudates 24 h PPI and incubated (1 × 106 cell/ml) in 
culture media under a humidified 5% CO2 atmosphere at 37°C for 
16–24 h or for 4 h with roscovitine (10 µM) to promote apoptosis. 
After culturing, each cell type was collected, and the percentage 
of apoptotic cells was detected using MEBCYTO apoptosis kit 
(MBL). In some experiments, PMNs were treated with protease 
inhibitor (diluted 1:25), CHX (30  mM), or silevestat (40  nM), 
concomitantly with roscovitine and then analyzed for Lf content 
by Western blotting. In some experiments, the neutrophils 
were stained for CXCR4 and Annexin V and analyzed by flow 
cytometry.
apoptotic cell engulfment Ex Vivo
Neutrophils or macrophages were isolated from peritoneal exu-
dates 24 or 66 h after zymosan A injection, respectively, using 
EasySep® Selection Kit following the manufacturer’s instructions 
(Stem Cells Technologies Inc.) with primary antibodies directed 
against Ly-6G and F4/80, respectively. Then, macrophages were 
incubated with either apoptotic Jurkat T cells or senescent PMNs 
(1:5 ratio) for 24 h. Next, unbound cells were washed with PBS 
and the adherent cells were lysed with radioimmunoprecipitation 
assay (RIPA) buffer containing protease inhibitor cocktail for 
20 min on ice, followed by centrifugation (15,000 RPM, 4°C) for 
15 min and collection of supernatants.
interstitial Fluids (isFs) From lymphoid 
Organs
Inguinal LN and spleens were harvested from mice 24 or 66 h 
PPI. The organs were mechanically dissociated and strained 
through a 100-µm nylon mesh (Beckton-Dickinson) to produce 
a single cell suspension, followed by separation of cells from ISF 
by centrifugation (1,200 RPM for 5 min). Then, red blood cells 
were lysed using RBC Lysis Buffer (biological industries), and 
both fluids and cells were saved at −20°C for further analysis. 
ISFs were added with a sample buffer and analyzed by Western 
blotting for Lf.
Mastitis Milk sample Preparation
Milk samples were obtained from three different dairy cow farms. 
Samples were taken from cows undergoing resolving or non-
resolving E. coli-induced mastitis or from healthy cows based 
on farmer’s criteria. The farmers’ criteria for resolving mastitis 
were high somatic cell counts and a swollen and red udder that 
resolved to a healthy state within 7–10 days. The milk initially 
became watered-down but later restored normal complexion. 
Non-resolving mastitis had the same diagnosis parameters ini-
tially, but instead of resolving, the milk became bloody and the 
udder became painful upon touching and eventually clogged. In 
order to separate the cellular and fat fraction from the aqueous 
fraction, samples were centrifuged at 1,200 RPM for 5 min (cel-
lular fraction), and the supernatants were incubated overnight 
at 4°C to solidify the fat fraction. Then, the fat fraction was 
mechanically peeled from samples and sample buffer was added 
to the samples. Equal milk volumes were analyzed by Western 
blotting for Lf.
Purification of lf-Derived Fragments
Mastitis milk samples from day 5 of resolving mastitis were 
defatted by centrifugation at 2,000 ×  g for 30  min at 4°C. The 
pH of the skim milk was adjusted to 4.6 with 5 N HCl and the 
milk was centrifuged at 10,000 × g for 1 h to remove the casein 
precipitate. The whey was then passed through a 0.45-mm filter 
(Millipore) to completely remove the casein precipitate and its pH 
was readjusted to 6.0 with 1 N NaOH. The immunoglobulin in 
the whey was removed by ammonium sulfate precipitation (48%). 
After passing through a 0.45-mm filter, the solution in the whey 
was replaced with 0.005  M sodium phosphate buffer (pH 6.0) 
using dialysis bag (33 mm cellulose membrane, 12–14 kDa cutoff, 
Sigma-Aldrich). Dialysis was performed in two repetitions, for 
5 h and consequently overnight with stirring in a high volume 
of 0.005 M sodium phosphate buffer (pH 6.0) at 4°C. Then, the 
samples were loaded into a heparin affinity column (Affi-gel 
Heparin gel, Bio-Rad), washed and eluted by a stepwise elution 
with increasing salt concentrations (0.005 M sodium phosphate 
buffer; pH 6.0, containing 0.1, 0.3, or 0.5 M NaCl). The proteins 
were then collected at the 0.5 M NaCl fraction, and its content was 
assessed by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) followed by Coomassie Blue staining and 
Western blotting for Lf (SantaCruz).
Western Blotting
Isolated cells were washed with PBS and lysed in RIPA buffer 
containing Protease Inhibitors Cocktail (1:25 dilution, Roche). 
Cell lysates, ISF, milk samples or isolated Lf derivatives were 
added with a sample buffer, run by SDS-PAGE (7.5 or 10%), 
and then transferred to a polyvinylidene difluoride membrane. 
The membranes were blocked with 5% BSA and probed with 
primary rabbit anti-mouse Lf polyclonal IgG (SantaCruz). 
Next, the membranes were blotted with appropriate secondary 
antibodies (1:10,000 dilution, 1 h at room temperature, Jackson 
ImmunoResearch) conjugated with horseradish peroxidase. 
Membranes were developed with WesternBright™ ECL kit 
(Advansta) and analyzed using Luminescent Image Analyzer 
LAS-4000 (Fujifilm Corporation) and “Image Reader LAS-4000” 
software (Fujifilm Corporation). Densitometric analysis was 
performed using TotalLab TL100 (nonlinear dynamics) image 
analysis software.
lf Fragment sequencing
The Coomassie-stained bands corresponding to the 15- and 
17-kDa fragments of bovine Lf from milk samples were proteomi-
cally analyzed at the Smoler Proteomics Center, The Technion, 
4Lutaty et al. Lf Fragments Limit Inflammation
Frontiers in Immunology | www.frontiersin.org March 2018 | Volume 9 | Article 644
Israel, according to the following protocol: the proteins in each 
sample were denatured in 8 M urea, reduced with 3 mM DTT 
(60°C for 30 min), and modified with 10 mM iodoacetamide in 
100 mM ammonium bicarbonate (room temperature for 30 min). 
The urea was diluted to 2 M, and the sample was trypsinized in 
10  mM ammonium bicarbonate containing trypsin (modified 
trypsin; Promega) at a 1:50 enzyme-to-substrate ratio, overnight 
at 37°C. A second step of trypsinization was performed by adding 
another portion of trypsin and incubation at 37°C for 4 h. Mass 
spectrometry was done according to the following protocol: the 
resulting peptides were desalted using C18 tips (homemade), 
dried, and re-suspended in 50  mM Hepes (pH 6.4). Labeling 
by dimethylation was done in the presence of 100 mM NaCBH3 
(Sterogene 1 M), by adding light formaldehyde (35% Frutarom, 
12.3  M) to one of the samples and heavy formaldehyde (20% 
w/w, Cambridge Isotope Laboratories, 6.5 M) to the other sam-
ple to a final concentration of 200 mM. After 1-h incubation at 
room temperature, the pH was raised to 8 and the reaction was 
incubated for 1 h. Neutralization was done with 25 mM ABC for 
30 min, and equal amounts of the light and heavy peptides were 
mixed, cleaned on C18, and re-suspended in 0.1% formic acid. 
The peptides were resolved by reverse-phase chromatography 
on 0.075 × 200-mm fused silica capillaries (J&W) packed with 
Reprosil reversed phase material (Dr. Maisch GmbH, Germany). 
The peptides were eluted with linear 90-min, gradients of 5–45% 
and 15 min at 95% acetonitrile with 0.1% formic acid in water at 
flow rates of 0.25 µl/min. Mass spectrometry was performed by 
an ion-trap mass spectrometer (Orbitrap, Thermo) in a positive 
mode using repetitively full MS scan followed by collision-
induced dissociation (CID) of the seven most dominant ions 
selected from the first MS scan.
The mass spectrometry data were analyzed using the Sequest 
3.31 software (J. Eng and J. Yates, University of Washington and 
Finnigan, San Jose) searching against the bovine part of the 
NCBI-NR database. Peptide quantities were calculated as area 
under the pick using the PepQuant algorithm from Bioworks.
sequence alignment
Sequences from the identified peptides were aligned relative to 
full-length Lf using STRAP, Interactive Structure based Sequence 
Alignment Program,1 along with PubMed protein database.2 For 
an illustration of the complete isolation and sequencing proce-
dure, please see Figure S2 in Supplementary Material.
Macrophage cD11b expression
Peritoneal exudates were recovered from mice 66 h PPI follow-
ing treatment for 18 h with vehicle, FKD, or FKE peptides. The 
cells were enumerated and immune-stained for Gr-1, F4/80, 
and CD11b and analyzed by flow cytometry (FACSCanto II) for 
leukocyte subtypes. F4/80+ macrophages were analyzed for the 
expression of CD11b as previously (9).
1 www.bioinformatics.org/strap/.
2 www.ncbi.nlm.nih.gov/pubmed/.
In Vivo efferocytosis
Peritoneal macrophages from Section “Macrophage CD11b 
Expression” were isolated using F4/80-directed magnetic beads, and 
150 × 103 cells were plated in an 8-well glass chamber slide (Nunc) 
for 2 h in 150-µl culture medium. Then, medium was aspirated, and 
unbound cells were washed gently with PBS. Adherent cells were 
subsequently fixed (200 µl of 4% paraformaldehyde, 5% sucrose, 15 
min). Next, the cells were washed in PBS and stained (overnight, 
4°C) with 200 µl of CF488A-conjugated phalloidin (5 U/ml from 
Biotium), for F-actin. Next, cells were washed three times with PBS 
and stained for nuclear DNA in 200 µl of Hoechst (20 µg/ml, 5 min, 
from Invitrogen), and rinsed with PBS. Then, the chambers were 
removed, mounted with Fluoromount G, and visualized under a 
Nikon A1 confocal microscope. The number of engulfed apoptotic 
cells per macrophage was scored, as well as the percentage of non-
engulfing macrophages. The results were obtained from eight mice 
and 503–592 macrophages per treatment.
Macrophage cytokine secretion
Peritoneal macrophages from Section “Macrophage CD11b 
Expression” were isolated and then treated with LPS (1 µg/ml, 24 
h) or vehicle. Then, culture media were collected and its cytokine 
content was determined by standard ELISA for TNFα, IL-6, 
IL-10, or IL-12.
regulation of aggneTs Formation
All analyses of material derived from human subjects were 
performed in full agreement with institutional guidelines and 
with the approval of the Ethical Committee of the University 
Hospital Erlangen (permit number 193 13B). Peripheral blood 
PMNs (>95% neutrophils) were separated from mononuclear 
cells by density gradient centrifugation on Lymphoflot (Bio-Rad, 
Hercules, CA, USA) and cleared from contaminating erythro-
cytes by short hypotonic lysis. PMNs were incubated at a low 
cell density (5 × 106 cells/ml) with 50 pg/cell MSU crystals and/
or 10–100  µM Lf (Sigma-Aldrich) and/or 10–100  µM FKD or 
FKE peptides and 1 µg/ml propidium iodide solution in RPMI 
(Thermo Fisher Scientific) without serum supplementation for 
3 h at 37°C and 5% CO2. NET aggregation was stopped by adding 
1% paraformaldehyde to cell cultures for 20 min. NET aggregates 
were filtrated through a 40-µM mesh, and macrophotographs of 
captured material with UVB transillumination were made with a 
Nikon D700 reflex camera.
Data analysis
Experimental data were analyzed by Student’s t-test or ANOVA 
followed by Tukey’s post  hoc analysis. p-values of ≤0.05 were 
designated as statistically significant. Results are presented as 
average ± SEM.
resUlTs
resolution Phase Macrophages acquire  
lf From senescent PMn
During the resolution of inflammation, macrophages engulf 
apoptotic PMN and consecutively migrate to lymphoid organs 
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(9, 23). Macrophages acquire granular defensins from neutrophils 
that had undergone apoptosis and “recycle” it for antimicrobial 
activity (8). Lf is a major constituent of neutrophils secondary 
granules. We hypothesized that Lf is acquired by macrophages 
once they engulf senescent PMN. To test this, we incubated neu-
trophils with resolution phase macrophages from the peritoneum 
ex vivo and quantified their levels of Lf. Apoptotic Jurkat T cells, 
latex beads (LBs), IgG-opsonized LB (oLB), and anti-CD11b 
antibodies were used as phagocytosis and CD11b crosslink-
ing controls, respectively. The results in Figure  1A show that 
macrophages contained only a single 50-kDa band immunoreac-
tive with anti-Lf antibodies. Incubation with aging/senescent 
FigUre 1 | Continued
FigUre 1 | (a,B) Lactoferrin (Lf) fragments accumulate in macrophages following incubation with senescent neutrophils. (a) Peritoneal macrophages were 
recovered 66 h post zymosan A-induced (1 mg/mouse) peritonitis initiation and incubated with apoptotic Jurkat cells (AC), senescent peritoneal neutrophils (SN), 
latex beads (LBs), IgG-opsonized LB (oLB), or anti-CD11b monoclonal antibodies as indicated. After 24 h, unbound cells were washed and macrophages were 
recovered. Then, the cells were lysed, and equal amounts of protein extract were blotted for Lf. Protein extracts from apoptotic neutrophils were also analyzed as 
indicated. Results are representative from three independent experiments (cells were pooled from three to five mice). (B) Peritoneal neutrophils were recovered 24 h 
PPI and treated with roscovitine (10 µM) alone or with protease inhibitor cocktail (Pi), cycloheximide (CHX), or the neutrophil elastase inhibitor, silevestat (NEi) for 20 
h. Then, neutrophils were lysed, and their protein content was immunoblotted for Lf [results are representative from three experiments (cells were pooled from three 
to five mice)]. (c,D) Lf fragments are found in interstitial fluids (ISFs) of spleen and inguinal lymph nodes (LN) during peritonitis. Spleen (c) and inguinal LN (D) were 
harvested 24 and 66 h after initiation of peritonitis (n = 4–5) and mashed in equal volumes of PBS employing a nylon grid. Equal amounts of ISF protein were run by 
10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS–PAGE), followed by Western blotting for Lf. Results are representative blots from three 
experiments. (e–g) Peritoneal resolution phase macrophages are essential for the differential production of splenic Lf fragments. Mice were injected intraperitoneally 
(i.p.) with clodronate-containing or empty liposomes 42 h PPI or before the initiation of peritonitis. After additional 24 h, the spleens were recovered and mashed in 
equal volumes of PBS employing a nylon grid. Equal amounts of ISF protein were run by 12% SDS-PAGE, followed by Western blotting for Lf. Results are a 
representative blot (e) and averages of densitometric analysis of the 23- (F) and 17 (g)-kDa bands from three experiments (n = 3–6 mice per group). **/*indicate 
statistically significant differences of P ≤ 0.01/P ≤ 0.05, respectively, by ANOVA with Tukey post hoc analysis. (h) Lf fragments are found in dairy cow milk during the 
onset and resolution of mastitis. Milk samples from dairy cows with mastitis (days 1–7) were defatted and separated into soluble and cellular fractions by 
centrifugation. The cellular fraction was lysed and the cytoplasmic proteins were recovered. Equal amounts of protein from both fractions were analyzed by  
Western blotting for Lf. Results show representative blots from three sample sets taken daily from three different cows.
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neutrophils resulted in the appearance of an additional 78-kDa 
protein similar to the major band corresponding to neutrophil-
borne Lf. Interestingly, the expression of the 50-kDa band in 
macrophages was not significantly modulated by incubation 
with apoptotic Jurkat cells or other phagocytic targets, such as 
LB and oLB. Crosslinking of CD11b did not modulate Lf levels 
in resolution phase macrophages either. To determine whether 
Lf fragmentation already takes place in PMN or whether Lf is 
expressed de novo in PMN, the recovered cells were treated with 
roscovitine in the presence of a general protease inhibitor cocktail, 
an elastase inhibitor (silevestat), or CHX. The results in Figure 1B 
indicate that roscovitine treatment enhanced Lf fragmentation 
to shorter fragments than 50 kDa already in unengulfed PMN. 
A fragment of 17 kDa was especially evident in apoptotic PMN. 
Moreover, both protease inhibitors significantly abrogated the 
generation of the 17-kDa Lf fragment, whereas CHX increased 
this Lf fragment levels. It was previously shown that senescent 
neutrophils express CXCR4 and migrate to the BM once they 
age through CXCL12 gradients (24). Of interest, the aging of 
peritoneal neutrophils ex vivo resulted in membrane expression 
of both annexin V and CXCR4 on most cells after 24 h (Figure S1 
in Supplementary Material), and this was enhanced by roscovi-
tine at 4 h, but not at 24 h. This indicates that aging PMNs have 
features of both apoptotic and senescent neutrophils. Altogether, 
these results indicate that Lf was processed, at least partially, in 
neutrophils during the apoptotic process, and consequently Lf 
and its fragments were acquired by resolution phase macrophages 
following the phagocytosis of apoptotic cells. Thus, macrophages 
can acquire Lf and its fragments from senescing neutrophils fol-
lowing their engulfment and maintain it as distinct fragments.
resolution-associated Fragments of lf 
are Present in Murine Draining ln and 
spleen as Well as Bovine Udder
Next, we analyzed whether Lf fragments can be detected in lym-
phoid tissues during inflammation and its resolution, since mac-
rophages that engulf apoptotic PMN tend to adopt the CD11blow 
phenotype and migrate to lymphoid organs (9). To this end, we 
collected ISFs from meshed inguinal LN and spleens 24 and 66 h 
post initiation of murine peritonitis. Our results in Figures 1C,D 
show three specific bands corresponding to Lf fragments that 
were detected in both spleen and LN with molecular weights of 
23, 17 and 15 kDa. Notably, the 23-kDa fragment was present at 
a higher amount during the inflammatory phase of the response 
(24 h) in comparison to the resolution phase (66 h) in both organs. 
The 15-kDa fragment showed a similar trend in the LN but did 
not reduce during the resolution phase in the spleen. Importantly, 
the 17-kDa fragment of Lf showed the opposite trend in both 
spleen and LNs. Essentially, its levels were significantly increased 
during the resolution phase compared to the inflammatory phase 
of peritonitis. To determine whether processing and/or release 
by peritoneal macrophages is key to determining the different 
fragments of Lf present at the spleen, we depleted peritoneal 
macrophages using clodronate 24 h prior to spleen recovery. Our 
results (Figures  1E–G) indicate that the depletion of resident 
macrophages did not affect the levels of either the 23- or 17-kDa 
fragments of Lf in the ISF at 24 h PPI. However, the depletion of 
resolution phase macrophages significantly reduced the levels of 
the 17-kDa fragment and increased the levels of the 23-kDa frag-
ment at 66 h PPI. Thus, our results suggest that the inflammatory 
23-kDa fragment of Lf is produced primarily by other cells, while 
the resolution phase-associated 17-kDa fragment is acquired and 
released by peritoneal macrophages that engulf PMN and migrate 
to the spleen.
Lactoferrin is a major component of milk and plays a key role 
in innate immune defense. We aimed to determine whether Lf 
fragments are also present in bovine milk during mastitis and 
its resolution, since neutrophils and macrophages increased in 
bovine milk during inflammation (25, 26). Our previous results 
determined that Lf fragments are accumulating in macrophages. 
Therefore, we sought to determine whether Lf fragments are 
also present in bovine milk during mastitis and its resolution. 
To this end, protein samples from the soluble and cellular 
fractions of bovine milk were collected daily during resolving 
mastitis (Figure S2 in Supplementary Material for Methodology; 
Figure 1H). As controls, milk samples were also collected from 
non-resolving mastitis as well as from healthy cows (Figure 
FigUre 2 | Isolation and identification of lactoferrin (Lf)-derived fragments from udders with resolving inflammation. Milk samples from cows with mastitis (day 5, 
early phase of resolution) were defatted and run on heparin gel columns. The bound proteins and fragments were eluted stepwise with 0.005 M sodium phosphate 
buffer (pH 6.0) containing 0.1, 0.3, or 0.5 M NaCl. The recovered protein samples were run on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) followed with Western blotting for Lf (a), and Coomassie Brilliant Blue staining for total protein content (B). The bands corresponding to the 15- and 
17-kDa fragments of Lf were excised from the gel and analyzed by LC-MS-MS. Quantification of the frequency of each fragment was provided by analysis of area 
under the peak. The indicated fragments were aligned using STRAP software against the full-length Lf sequence taken from the PubMed database. Then, each 
peptide was associated with the corresponding fragment of 15 or 17 kDa (inset, highlighted in blue and red, respectively). One common peptide present in both 
fragments is highlighted in orange (c).
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S3 in Supplementary Material). Our results indicate a similar 
fragmentation pattern for murine and bovine Lf. Moreover, 
during spontaneous resolution of mastitis, the amounts of the 
17-kDa fragment of soluble Lf increase from day 1 until day 7. 
Concomitantly, the amounts of the 23- and 15-kDa fragments 
of Lf were decreased during the transition from the inflamma-
tory phase to the resolving phase. The full-length 78-kDa Lf and 
its 50-kDa fragment are evident only at the beginning of the 
inflammatory episode (day 1) and during the late resolution 
phase of mastitis (days 6 and 7), while during the course of early 
inflammation, its levels are very low. Importantly, the 50- and 
17-kDa fragments of Lf were also found in the cellular frac-
tion of the milk from resolving mastitis, albeit in kinetics that 
preceded the soluble fraction by 24 h. This suggested that the 
soluble fragments originated in leukocytes that infiltrated into 
the infected udder. In non-resolving mastitis, the prevalence of 
Lf fragments was different from that of resolving mastitis. Only 
the 50-kDa fragment is evident in non-resolving mastitis, and 
FigUre 3 | Lactoferrin (Lf)-derived peptides promote macrophage conversion to the CD11blow phenotype. Mice undergoing peritonitis for 48 h were injected 
intraperitoneally (i.p.) with PBS, FKE, or FKD peptides (50 µM each). After additional 18 h, peritoneal exudates were recovered and the cells were enumerated. Then, 
exudate cells were immunostained for Ly-6G, F4/80, and CD11b and analyzed by flow cytometry. The numbers of macrophages (a) and neutrophils (B), and the 
percentages of CD11bhigh and CD11blow macrophages (c) are presented. Results are averages ± SEM from three independent experiments (n = 4 per group). 
***/**/*indicate statistically significant differences of P ≤ 0.005/P ≤ 0.01/P ≤ 0.05, respectively, by ANOVA with Tukey post hoc analysis.
8
Lutaty et al. Lf Fragments Limit Inflammation
Frontiers in Immunology | www.frontiersin.org March 2018 | Volume 9 | Article 644
its levels in the milk increased with time. Altogether, our find-
ings indicate that Lf undergoes a distinct proteolytic processing 
during inflammation and its resolution in various organs and 
mammals, and that a leukocyte-derived 17-kDa fragment accu-
mulates in various immune-active organs during the resolution 
of inflammation.
isolation of lf-Derived Fragments and 
Determination of Their amino acid 
sequences
Next, we isolated the 17-kDa fragment of Lf from milk collected 
during the resolution of mastitis and determined its amino acid 
sequence, to identify novel resolution-associated molecules. To 
this end, milk samples from day 5 of mastitis were prepared and 
loaded on heparin liquid-gel columns. After washing of unbound 
material, the eluted products were run on 10% SDS-PAGE, blot-
ted by anti-Lf antibodies, and visualized by Coomassie Brilliant 
Blue staining (Figures 2A,B). The bands at 17 and 15 kDa were 
identified as Lf fragments by Western blotting and therefore 
were excised from the gel and used for amino acid sequencing 
using mass spectrometry. No other small Lf-derived fragments 
were detected in our isolated proteins, suggesting that the other 
fragments found in bovine milk do not bind heparin. The pro-
teomic analysis of the 15- and 17-kDa fragments of Lf resulted 
in a series of peptides with relative quantities (Figure 2C) that 
were aligned to the amino acid sequence of full-length bovine 
Lf as well as to Lf sequences from eight other species taken from 
the PubMed database. These species include Homo sapiens, Mus 
musculus, and two subgroups of the bovine family: Bos indicus 
and Bos taurus. Alignment, amino acid coloring, frame shift, and 
amino acid numbering were done using the STRAP software 
(Figure S4 in Supplementary Material). Our analysis was based 
on the notion that our anti-Lf antibody was generated against 
a peptide comprising amino acids 146–210, and therefore this 
portion of Lf should be included in both the 15- and 17-kDa 
fragments. Our results revealed that the 15-kDa fragment 
was composed of eight peptides that encompassed amino 
FigUre 4 | FKE peptides promote macrophage efferocytosis. Mice 
undergoing peritonitis for 48 h were injected intraperitoneally (i.p.) with PBS, 
FKE, or FKD peptides (50 µM each). After additional 18 h, peritoneal 
macrophages were isolated and stained with CF488A-conjugated phalloidin 
and Hoechst. Slides were visualized under a Nikon A1 confocal microscope 
and nuclei of engulfed polymorphonuclear cells (PMN) were enumerated [see 
(a) for a representative image]. Results show the average number of engulfed 
apoptotic PMN per macrophage (B) and the percentage of macrophages 
that did not engulf apoptotic PMN (c). Results are averages ± SEM from 
three independent experiments (n = 4 per group). *indicate statistically 
significant differences of P ≤ 0.05 by ANOVA with Tukey post hoc analysis.
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acids 19–183 (including the peptides 27WCTISQPEWFK38, 
47KLGAPSITCVRRAFALECIRA68, 72KADAVTLD80, 80GGM 
VFEAGRD90, 90PYKLRPVAAE100, 100IYGTKESPQT110, 110HYY 
AVAVVKK120, 120GSNFQLDQLQGR132, and 171FFSASCVPCI 
DR183). Most of these peptides also appeared with similar 
frequencies in the 17-kDa fragment analysis (probably due to 
dispersion of the 15-kDa band and inaccuracies in the excision 
process). However, a second molecular species was also evident. 
This fragment ranged from amino acids 171–343 (includ-
ing the peptides 171FFSASCVPCIDR183, 206EPYFGYSGAF216, 
217CLQDGAGDVAFVK230, 231ETTVFENLPEK241, 278SVDGKE 
DLIWK289, and 333VDSALYLGSR343; Figure  2C, insert). These 
designated amino acid sequences matched in predicted 
molecular weights to 15 and 17  kDa, respectively. Notably, 
another Lf peptide that was not detected by Western blotting 
was identified using mass spectrometry within the 17-kDa 
band. This fragment from the C-lobe of Lf (containing peptides 
598PVTEAQSCHLAVAPNHAVVSR619, 627QVLLHQQALFGK639, 
669LGGRPTYEEYL-GTEYVTAIANLKK693, and 693CSTSPLLEA 
CAFLTR708) was not further pursued as it is not known whether 
it is associated exclusively with the resolution phase of inflamma-
tion. Thus, we conclude that the 15- and 17-kDa fragments differ 
from one another, for the most part, with a short overlapping 
region in the domain that is recognized by the anti-Lf antibodies 
(Figure 2C, highlighted in orange).
The lf-Derived Peptides FKe and FKD 
Promote In Vivo Macrophage conversion 
to the Pro-resolving cD11blow Phenotype
Previously, Komine et al. (19) identified four peptides in ser-
ine protease-digested bovine Lf: FKECHLA, VPSHAVVAR, 
FQLFGSP, and PGQRDLLFKDSAL (designated pep1–4, 
respectively). All peptides are located within the 17-kDa Lf 
fragment (Figure S4 in Supplementary Material, underlined) 
and showed that pep4 had an enhanced pro-inflammatory effect 
in terms of cytokine and chemokine secretion in a bovine mam-
mary gland epithelial cell line (19), while pep1–3 were devoid 
of activity. Other results from the same group (20) showed that 
the human homolog of pep1 contains an FKDCHLA sequence, 
induced pro-inflammatory cytokines and chemokines (IL-8, 
IL-6, and MCP-1), and activated NF-κB in the HSC-2 cell 
line. The human homolog of pep 4 (SGQKDLLFKDSAI) was 
active as well. Thus, we suggest that the difference in immune-
modulatory properties between bovine pep4 and pep1 could 
be due to the replacement of a single aspartate by glutamate 
(D → E). As a result, the active consensus sequence changes 
from phenylalanine–lysine–aspartate (FKD) to phenylala-
nine–lysine–glutamate (FKE; Figure S4 in Supplementary 
Material, inside the red frame) and results in loss of activity 
under their experimental setting. Since our results indicate 
that both peptides are present in the 17-kDa Lf-derived frag-
ment that accumulates during the resolution of inflammation 
in various species and models, we determined whether these 
peptides exert anti-inflammatory and pro-resolving actions 
and whether the FKD and FKE peptides differ in this respect. 
To this end, FKD and FKE peptides (50 µM) were injected i.p. 
to mice undergoing peritonitis for 48 h. After additional 18 h, 
peritoneal exudates from these mice were recovered, and the 
properties of the leukocytes collected were determined. Our 
results (Figures 3A,B) indicate that FKD, and to a higher extent 
FKE, reduced peritoneal macrophage and PMN numbers (0.7- 
and 0.51-fold of PBS for macrophages, 0.77- and 0.69-fold of 
control for PMN, respectively), although the latter reduction 
was not statistically significant. Importantly, the conversion of 
macrophages from the reparative CD11bhigh phenotype to the 
pro-resolving CD11blow phenotype (9, 27) in the peritoneum 
was upregulated by FKD and to a higher extent by FKE peptides 
(Figure 3C; 1.13- and 1.33-fold of PBS, respectively).
FKe Peptides Promote Macrophage 
efferocytosis
It was previously shown that macrophage conversion to the 
CD11blow phenotype can be induced by apoptotic PMN uptake 
(9). Hence, we examined the impact of Lf peptides on effero-
cytosis in vivo. Our results in Figures 4A–C indicate that FKE 
increased efferocytosis, while FKD reduced it (1.17- and 0.57-fold 
of PBS, respectively). These responses were primarily due to a 
FigUre 5 | FKE peptides promote macrophage reprogramming. Mice undergoing peritonitis for 48 h were injected intraperitoneally (i.p.) with PBS, FKE, or FKD 
peptides (50 µM each). After additional 24 h, peritoneal macrophages were isolated and incubated ex vivo with lipopolysaccharide (LPS) (1 µg/ml, 24 h) or vehicle. 
Then, culture media were collected and its content of tumor necrosis factor α (TNFα) (a), interleukin (IL)-6 (B), IL-10 (c), and IL-12 (D) was determined by standard 
enzyme-linked immunosorbent assay. Results are representative (a,D) and averages ± SEM (B,c) from three experiments (n = 4 per group). ***/**/*indicate 
statistically significant differences of P ≤ 0.005/P ≤ 0.01/P ≤ 0.05, respectively, by ANOVA with Tukey post hoc analysis.
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decrease in non-efferocytic macrophages following FKE treat-
ment, while the percentage of these macrophages was increased 
by FKD (0.72- and 1.35-fold of PBS, respectively). Thus, FKE, 
but not FKD, peptides enhance the uptake of apoptotic PMN by 
resolution phase macrophages.
FKe Peptides Promote Macrophage 
reprogramming
The uptake of apoptotic cells promotes macrophage reprogram-
ming and results in a reduced secretion of pro-inflammatory 
cytokines and an increased secretion of anti-inflammatory/
reparative cytokines upon exposure to bacterial agents (5). 
Hence, we examined whether Lf peptides can affect macrophage 
reprogramming and cytokine secretion upon LPS stimulation. 
Our results indicate that FKE exposure in vivo reduced TNFα and 
IL-6 secretion by LPS-stimulated resolution phase macrophages 
[(Figures 5A,B); 0.79- and 0.81-fold of PBS, respectively]. FKD 
peptides, on the other hand, increased the secretion of these 
inflammatory cytokines from LPS-stimulated resolution phase 
macrophages [(Figures 5A,B); 1.66- and 1.2-fold of PBS, respec-
tively]. Notably, IL-10 secretion was induced by FKE, but not 
by FKD [(Figure 5C); 1.72- and 0.98-fold of PBS, respectively], 
whereas both peptides reduced IL-12 secretion but not in a statis-
tically significant manner (Figure 5D). Thus, FKE, but not FKD, 
seems to promote macrophage reprogramming during resolving 
inflammation.
lf-Derived Peptides enhance MsU-
induced aggneTs Formation
The resolution of neutrophilic inflammation was recently shown 
to be associated with the formation of cytokine-scavenging agg-
NETs displaying a tophus texture (21). Since Lf promotes human 
FigUre 6 | Lactoferrin (Lf)-derived peptides induce aggregated neutrophil extracellular traps (aggNETs) formation. Human polymorphonuclear cells (PMN) from three 
healthy donors were freshly isolated from peripheral blood and seeded in a final cell density of 5 × 106 cells/ml. PMNs were incubated with 50 pg/cell monosodium 
urate crystals (MSU) and/or 10–100 µM Lf (LF) and/or 10–100 µM FKD or FKE peptides and 1 µg/ml propidium iodide solution. NET aggregation was stopped by 
fixation and aggNETs formed were filtrated through a 40-µM mesh. Macrophotographs with UVB transillumination were captured with a Nikon D700 reflex camera 
(a). Averages ± SEM of fluorescence values from three independent donors of the images of control, MSU, and MSU + Lf (B) and MSU + FKD/FKE peptides at the 
indicated concentrations (c). **/*indicate statistically significant differences of P ≤ 0.01/P ≤ 0.05, respectively, by ANOVA with Tukey post hoc analysis.
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neutrophil aggregation at low density, we determined whether 
Lf, Lf peptides (LFPs), or combinations of these agents also 
promote aggNETs formation. To this end, we added FKE or FKD 
peptides alone or together with full-length Lf to MSU crystals in 
NETs formation and aggregation assays. Our results show that 
treatment with FKE enhanced MSU-induced aggNETs formation 
at 100  µM, whereas FKD did it to a lower and nonstatistically 
significant manner (Figure  6A). Full-length Lf reduced MSU-
induced aggNETs formation in a concentration-dependent (but 
not statistically significant) manner at 30–100 µM (Figure 6B). 
Surprisingly, this effect was enhanced by FKE and FKD peptides 
(at 100  µM) in a statistically significant manner (compared 
to MSU alone; Figure 6B). Notably, FKD (at 30 µM) and FKE 
(at 100 µM) modulated MSU-induced aggNETs formation in a 
significantly different manner than Lf (Figure 6C), suggesting 
that the fragmentation of Lf is necessary for it to enhance the 
resolution of inflammation through aggNETs formation. We 
conclude that LFP enhances aggNETs formation by human neu-
trophils and thus contributes to the resolution of inflammation.
DiscUssiOn
Rapid engulfment of senescent PMN by macrophages during 
the resolution phase of inflammation causes the accumulation 
of stodgy cellular remnants in phagolysosomes that is congruent 
with the satiation of the engulfing macrophages (9). Macrophages 
have developed specific molecular mechanisms to cope with this 
burden (28). We hypothesized that Lf, a major neutrophil con-
stituent that contains several proteolytic peptides with variable 
actions, can be processed during neutrophil apoptosis into bio-
active fragments that accumulate in the engulfing macrophages. 
These will in turn be released and regulate both inflammation and 
its resolution. Since macrophages are emigrating from inflamma-
tory and resolving tissues to remote sites (9, 23, 29), they can 
release Lf-derived products either locally or at their final destina-
tion. Our results in Figure 1 indicate that a truncated form of 
Lf with 50 kDa is to be found in resolution phase macrophages 
and that the latter can acquire Lf from apoptotic PMN but not 
from engulfment of other apoptotic cells or phagocytic targets. 
Our results indicate that Lf and its fragments found in these 
macrophages are not expressed de novo, but rather accumulating 
following efferocytosis. The Lf is cleaved in either PMN or mac-
rophages to yield smaller fragments of 23, 17, and 15 kDa, which 
can robustly be found in murine ISFs from spleen and inguinal 
LN and in the udder of cows inflicted by mastitis. Importantly, we 
also detected these Lf fragments in macrophages or immune cells 
collected at inflammatory sites. Of particular interest, the Lf frag-
ments showed different kinetics. The 23- and 15-kDa fragments 
were associated with the inflammatory phase, while the 17-kDa 
fragment increased during the resolving phase of inflammation. 
Moreover, the levels of splenic 17-kDa fragment were reduced 
upon peritoneal macrophage depletion during the resolution 
FigUre 7 | A schematic illustration of the proposed model of generation and action of lactoferrin (Lf) fragments and peptides during the resolution of inflammation. 
(a) During inflammation and its resolution, neutrophils undergo apoptosis and get engulfed by macrophages. This process is accompanied by neutrophil 
elastase-mediated cleavage of Lf and generation of the 17-kDa fragment. (B) The engulfed polymorphonuclear cell (PMN) corpses traffic to the phagolysosome 
where most of their cellular components are hydrolyzed. Lf fragments are accumulating in resolution phase macrophages during the inflammatory and resolving 
phases of the response. 15- and 17-kDa fragments were produced during the inflammatory phase and the resolution of inflammation, respectively. The 17-kDa Lf 
fragment is released and possibly undergoes further processing to shorter peptides containing the tripeptides FKE and FKD. (c) Both peptides enhance 
macrophage conversion to the CD11blow phenotype, whereas FKE peptides enhance macrophage efferocytosis in vivo. FKE peptides also promote macrophage 
reprogramming in vivo culminating in a reduced secretion of tumor necrosis factor α (TNFα) and interleukin (IL)-6, and an increased secretion of IL-10 upon 
exposure to LPS. (D) Lf peptides also promote the generation of pro-resolving aggregated neutrophil extracellular traps (aggNETs) in monosodium urate 
(MSU)-activated human neutrophils, while Lf fails to do so. Intriguingly, when combined with full-length Lf, Lf peptides enhance its inhibition of aggNETs formation 
following MSU exposure. Altogether, these findings suggest that Lf undergoes specific proteolytic processing to yield functional fragments that are released and 
“recycled”. These fragments contain bioactive peptides with anti-inflammatory and pro-resolving properties that orchestrate the resolution of neutrophil-driven 
inflammation.
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phase, whereas the levels of the 23-kDa fragment were increased. 
Thus, apoptotic PMN and efferocytic macrophages processed Lf, 
and the later cells released its fragments in a spatially and tempo-
rally regulated manner during the inflammatory responses. Since 
the inflammatory 23- and 15-kDa fragments of Lf were not found 
in apoptotic PMN, it is not clear whether they are generated by 
diversion of the proteolytic cascade in PMN that were engulfed, 
the efferocytic macrophages themselves or cleavage of secreted Lf 
at local or remote sites.
Notably, during bacterial infection, a Lf fragment with 22 kDa 
was previously described in bovine and human samples (19, 
20). This fragment contained four peptides generated by the 
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serine proteases elastase and proteinase 3. One of these peptides 
with the sequences PGQRDLLFKDSAL/SGQKDLLFKDSAI 
in bovine and human Lf, respectively, induced cytokine and 
chemokine secretion in epithelial cells. Another peptide present 
in human Lf, FKDCHLA, induced inflammatory cytokine 
secretion, while its bovine homolog FKECHLA was inactive. 
It seems that the FKD tripeptide present in the first three pep-
tides might account for their activity while the replacement of 
aspartic acid (D) to glutamic acid (E) results in the abortion of 
the stimulatory activity. Hence, we examined whether FKE or 
FKD peptides can shift resolution indices in vivo. Our previous 
studies (9) showed that a distinct subset of pro-resolving mac-
rophages designated CD11blow macrophages were converted from 
CD11bhigh ones upon satiated efferocytosis of apoptotic PMN. 
These macrophages produced reduced levels of inflammatory 
cytokines and increased levels of tumor growth factor β (TGFβ) 
in comparison to their CD11bhigh counterparts. Earlier studies 
have shown that the uptake of apoptotic cells by monocyte/mac-
rophage leads to their reprogramming that is accompanied by a 
reduced inflammatory cytokine production and increased IL-10 
and TGFβ secretion (30, 31). Our current results indicate that 
FKE, and to a lesser degree FKD, reduced macrophage numbers 
in the peritoneum while increasing the percentage of CD11blow 
macrophages (Figure  3). In addition, FKE peptides promoted 
efferocytosis of apoptotic PMN (Figure 4) and reduced TNFα 
and IL-6 secretion while increasing IL-10 secretion by resolu-
tion phase macrophages in response to LPS, while FKD peptides 
exerted opposite actions (Figure  5). Altogether, our findings 
suggest that peptides present within the resolution-associated 
fragment of Lf can modulate resolution phase macrophage 
reprogramming toward a pro-resolving phenotype, with FKE 
having superior actions to FKD.
Lactoferrin has previously been shown to enhance MSU-
induced aggregation of neutrophils at a low cellular density in 
PBS (21), but to limit phorbol myristate acetate-induced NET 
formation due to its positively charged amino acids (32). These 
apparently conflicting results can be explained by the activity of 
Lf in different in vitro conditions. In the presence of culture media 
like RPMI, full-length Lf has no effect on the formation of aggNETs 
induced by MSU crystals. Importantly, the FKE peptide, and to a 
lesser degree FKD, enhanced the pro-resolving action of MSU in 
promoting aggNETs formation even in low neutrophil densities 
(Figure 6). Both peptides had a significantly different impact than 
the parent protein, but surprisingly exerted an inhibitory effect 
on aggNETs formation when applied together with full-length 
Lf. Thus, LFP promoted human neutrophil-mediated resolu-
tion of inflammation by enhancing the generation of aggNETs, 
while full-length Lf failed to do so. These findings suggest that 
Lf cleavage and disposal of its positive charge are essential for its 
promotion of aggNETs formation (see Figure 7 for illustration).
In sum, the current report unveils the generation and release of 
Lf-derived fragments temporally changing during the initiation 
and resolution of inflammation. The fragment that is prevalent 
during the resolution phase contains bioactive peptides that 
promote pro-resolving actions of human neutrophils and mac-
rophages most likely through binding to surface receptors and 
intracellular signaling. These findings improve our understanding 
of the molecular aspects of resolving inflammation and may lead 
to novel Lf-based therapies for inflammatory conditions.
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FigUre s1 | Senescent peritoneal neutrophils are primarily apoptotic with 
CXCR4 expression. Mice were injected with zymosan A (1 mg/mouse, i.p.), and 
neutrophils were isolated from peritoneal exudates at 4 h post-peritonitis initiation 
(PPI), and incubated with roscovitine (10 µM) or vehicle for 4–24 h. Next, the 
neutrophils were immunostained for FITC-annexin V and PE-CXCR4 and 
analyzed by flow cytometry. Results are representative dot plots (a) and 
averages ± SEM (B) from five to six independent experiments. ***/*indicate 
statistically significant differences of P ≤ 0.005/P ≤ 0.05, respectively,  
by ANOVA with Tukey post hoc analysis.
FigUre s2 | Lactoferrin (Lf) fragment isolation and identification. Mastitis milk 
samples from dairy farms (a,B) were processed to separate the cellular and fat 
fractions from the aqueous fraction [(c–F), see Section “Materials and Methods” 
for details] and to prepare them for isolation of Lf peptides. To reduce the amount 
of low-molecular weight constituents, the samples were dialyzed (cutoff of 
12–14 kDa). Then, Lf fragments were isolated on heparin columns (g,h). After 
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stepwise elution with increasing NaCl concentrations, the samples were run on 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and the 
gel was stained with Coomassie Blue (i). Afterward, the 15- and 17-kDa bands 
were excised, digested, and analyzed by MS-MS mass spectrometry (J,K). The 
peptides contained in the fragments were identified and aligned in comparison to 
full-length Lf from various species (l). Adding quantitative properties of the 
MS-MS analysis and the known immunogenic epitope in both fragments allowed 
the determination of the fragment boundaries. The alignment of the various Lf 
species and the reports by Komine et al. allowed us to predict potentially 
bioactive peptides present in the 17-kDa fragment of bovine Lf. These peptides 
were synthesized and purchased from GL Biochem (Shanghai) Ltd. (M).
FigUre s3 | The 17- and 15-kDa fragments of lactoferrin (Lf) are absent in 
non-resolving and healthy dairy cow milk. Milk samples from none-resolving 
mastitis-inflicted dairy cows (days 1–4) or healthy (H) cows were separated 
into soluble and cellular fractions by centrifugation. The cellular fraction was 
lysed, and the cytoplasmic proteins were recovered. Equal amounts of 
protein from both fractions were analyzed by Western blotting for Lf. Results 
show representative blots from two sample sets taken daily from two 
different cows.
FigUre s4 | Alignment of the identified lactoferrin (Lf)-derived fragments to 
full-length Lf originated from different species. Protein bands corresponding to 
the 15- and 17-kDa fragments of Lf were sequenced using trypsin cleavage and 
mass spectrometry analysis. The sequences of the resulting peptides were 
aligned and compared to full-length Lf from nine species: Capra hircus, Equus 
caballus, Ovis aries, Sus scrofa, Camelus dromedarius, Bos indicus, Bos taurus, 
Homo sapiens, and Mus musculus, using STRAP software. Highlighted in yellow 
and in bright purple are peptides corresponding to the 15- and 17-kDa 
fragments, respectively. Positions 1–19 of all sequences (excluding E. caballus) 
serve as a signal peptide, and therefore amino acid numbering starts from the 
19th amino acid. Peptides produced by serine proteases and reported by 
Komine et al. (FKECHLA, VPSHAVVAR, FQLFGSP, and PGQRDLLFKDSAL from 
bovine Lf) are underlined. The sequences in the red frame indicate the minimal 
consensus sequences in the 17-kDa fragment that were predicted to be 
bioactive.
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